Target intelligence / Profile preview

67 kDa laminin receptor (Ribosomal protein SA) (67LR)

Target
67LR
Molecular classification
Receptor, Ribosomal protein, Cell adhesion molecule
01

Overview

The 67 kDa laminin receptor (67LR) is a non-integrin cell surface receptor encoded by the RPSA gene, which also functions as a component of the 40S ribosomal subunit (UniProt P08865). It is formed through the post-translational modification or dimerization of a 37 kDa precursor (37LRP) and is ubiquitously expressed in mammalian tissues. 67LR is a primary attachment receptor for Adeno-associated virus serotype 9 (AAV9), a vector widely used in gene therapy for its ability to cross the blood-brain barrier (Akache et al., 2006, J. Virol.). AAV9 entry is a multi-step process that also involves terminal N-linked galactose residues for initial docking and the Adeno-associated virus receptor (AAVR/KIAA0319L) for subsequent endosomal trafficking (Pillay et al., 2016, Nature; Shen et al., 2011, J. Biol. Chem.). In addition to its role in viral entry, 67LR is frequently overexpressed in various cancers, where it correlates with increased metastatic potential and poor prognosis by modulating cell adhesion and migration (Nelson et al., 2008, Cancer Lett.). It also serves as a receptor for the green tea polyphenol EGCG and has been implicated in the internalization of pathogenic prion proteins and amyloid-beta peptides, suggesting a role in neurodegenerative diseases.

Other names
37 kDa laminin receptor precursor37LRPRPSALAMR1Laminin-binding protein precursor p40LAMBRNEM/1-alpha
02

Mechanism of action

Acts as a high-affinity cell surface receptor for viral attachment and internalization, specifically for AAV9; also mediates cell-extracellular matrix adhesion by binding to laminin-1.

03

Biological functions

Cell adhesionViral entryRibosome assemblyProtein synthesisSignal transductionCytoskeletal organization
04

Disease associations

InfectionCancerNeurodegenerative diseasePrion disease
05

Safety considerations

Ubiquitous expression leading to off-target viral transduction in gene therapyPotential for immune response against the receptor-binding domain of viral capsidsRole in the internalization of pathogenic prion proteins and amyloid-beta
06

Interacting drugs

Onasemnogene abeparvovec (Zolgensma)

2 more in the full profile.

07

Biomarkers

67LR surface expressionRPSA mRNA levels

Beyond the preview

Go deeper on 67 kDa laminin receptor (Ribosomal protein SA) (67LR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 67 kDa laminin receptor (Ribosomal protein SA) (67LR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call